热景生物(688068)每日收评(07-09)

Group 1 - The stock of Rejing Bio (688068) has a strong overall score of 63.80 as of July 9, 2025, indicating a positive outlook [1][2] - The main cost analysis shows the current main cost at 184.00 yuan, with a 5-day average of 179.53 yuan, a 20-day average of 152.13 yuan, and a 60-day average of 133.13 yuan [1][2] - The stock has experienced 3 instances of hitting the upper limit and no instances of hitting the lower limit in the past year [1] Group 2 - The short-term resistance level is at 194.81 yuan, while the short-term support level is at 147.07 yuan [2] - The market trend is currently unclear, with a wait-and-see approach for the main funds to choose a direction [2] - The K-line pattern indicates a bullish outlook with a "solid bullish line" [2] Group 3 - On July 9, 2025, the net inflow of main funds was 64.97 million yuan, accounting for 9% of the total transaction volume [2][3] - The breakdown of fund inflows includes a net inflow of 50.48 million yuan from large orders and 14.49 million yuan from medium orders, while retail investors saw a net outflow of 2.33 million yuan [2][3] - The financial data shows an earnings per share of -0.26 yuan, an operating profit of -0.24 billion yuan, and a net profit of -24,566,770.04 yuan, with a sales gross margin of 47.268% [2][3] Group 4 - The stock is associated with sectors such as medical devices (0.01%), food safety (-0.09%), national security (-0.28%), and in vitro diagnostics (-0.16%) [2][3]